ADX-104 is a Reactive Aldehyde Substance (RASP) inhibitor that can be used in studies related to succinate semialdehyde dehydrogenase deficiency disease.
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
| Species | Mouse | Rat | Rabbit | Guinea pig | Hamster | Dog |
| Weight (kg) | 0.02 | 0.15 | 1.8 | 0.4 | 0.08 | 10 |
| Body Surface Area (m2) | 0.007 | 0.025 | 0.15 | 0.05 | 0.02 | 0.5 |
| Km factor | 3 | 6 | 12 | 8 | 5 | 20 |
| Animal A (mg/kg) = Animal B (mg/kg) multiplied by | Animal B Km |
| Animal A Km |
For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.
| Related RASP Products |
|---|
| ADX-248
ADX-248 is a Reactive Aldehyde Substance (RASP) inhibitor that can be used in studies related to geographic atrophy (GA). |
| ADX-246
ADX-246 is a Reactive Aldehyde Substance (RASP) inhibitor that can be used in studies related to autoimmune diseases. |
| ADX-103
ADX-103 is a RASP inhibitor that can be used in studies related to diabetic macular edema. |
| Acloproxalap
Acloproxalap is a quinoline-based inhibitor of reactive aldolization substances (RASPs) that can be used in studies related to toxic aldehyde-accumulating diseases. |
| Reproxalap
Reproxalap (ADX-102) is a reactive aldehyde species (RASP) sequestering agent for the treatment of dry eye. Reproxalap (ADX-102) covalently binds aldehydes including malondialdehyde and 4-hydroxynonenal. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
